{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/902628446",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/111658096"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/1746892004",
    "http://id.who.int/icd/release/11/2024-01/mms/1251780231",
    "http://id.who.int/icd/release/11/2024-01/mms/902628446/other",
    "http://id.who.int/icd/release/11/2024-01/mms/902628446/unspecified"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#902628446",
  "code": "CB07",
  "source": "http://id.who.int/icd/entity/902628446",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Lymphangioleiomyomatosis"
  },
  "definition": {
    "@language": "en",
    "@value": "Lymphangioleiomyomatosis (LAM) is a multiple cystic lung disease characterised by progressive cystic destruction of the lung and lymphatic abnormalities, frequently associated with renal angiomyolipomas (AMLs). LAM occurs either sporadically or as a manifestation of tuberous sclerosis complex (TSC)."
  }
}